Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
申请人:Bayer Aktiengesellschaft
公开号:US06262112B1
公开(公告)日:2001-07-17
The present invention relates to new aryl ether sulphonamides and analogs, processes for their preparation and their use for the treatment of neurodegenerative disorders, in particular for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy and craniocerebral trauma.
本发明涉及新的芳基醚磺酰胺及其类似物,其制备方法以及它们用于治疗神经退行性疾病的用途,特别是用于神经退行性疾病的预防和治疗,特别是用于治疗脑卒中和颅脑外伤。